Clinical significance of IL-18, IL-15, IL-12 and TNF-α measurement in rheumatoid arthritis

Clinical Rheumatology

Volumn 25, Issue 4, 2006, Pages 448-452

  Petrovic Rackov, Ljiljana ^a,b   Pejnovic, Nada ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Arthritis; Disease activity score; Interleukin; Synovial fluid; Tumor necrosis factor alpha

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; RELIABILITY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SERUM; STATISTICAL SIGNIFICANCE; SYNOVIAL FLUID LEVEL;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-18; MALE; OSTEOARTHRITIS; PREDICTIVE VALUE OF TESTS; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746488770     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0106-0     Document Type: Article

References (11)

1. Kawashima M, Miossec P (2004) Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis. Arthritis Res Ther 6:R39-R45
2. Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL et al (2003) Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 48(2):339-347
3. Leung PB, McInnes BI, Esfandiari E, Wei XQ, Liew YF (2000) Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J Immunol 164:6495-6502
4. Gracie AJ, Forsey JR, Ling Chan W, Gilmour A, Leung PB, Greer RM et al (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104:1393-1401
5. McInnes BI, Gracie AJ, Hornett M, Hornett W, Liew YF (2003) New strategies to control inflammatory synovitis: Interleukin 15 and beyond. Ann Rheum Dis 62:iI51-ii54
6. Prevoo LM, Hof AM, Kuper HH, Leeuwen AM, Putte BL, Riel LP (1995) Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum 38:44-48
7. Stone AM, Payne U, Pacheco-Tena C, Inman DR (2004) Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis. Ann Rheum Dis 63:84-87
8. Liew YF, McInnes BI (2002) Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 61:iI100-ii102
9. Bresnihan B, Roux-Lombard P, Murphy E, Kane D, FitzGerald O, Dayer MJ (2002) Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis. Ann Rheum Dis 61:726-729
10. Klimiuk AP, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J (2001) Serum cytokines in different histological variants of rheumatoid arthritis. J Rheumatol 28:1211-1217
11. Gonzalez-Alvaro I, Ortiz AM, Garcia-Vicuna R, Balsa A, Pascual-Salcedo Laffon A (2003) Increased serum levels of interleukin-15 in rheumatoid arthritis with long-term disease. Clin Exp Rheumatol 21(5):639-642